Hrt Financial LP Ac Immune Sa Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.35 - $4.47 $24,722 - $47,024	-10,520 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.5 - $5.16 $36,820 - $54,283	10,520 New	10,520 $42,000
Q3 2021 Nov 15, 2021	SELL	$6.2 - $8.34 $117,043 - $157,442	-18,878 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.04 - $8.37 $114,023 - $158,008	18,878 New	18,878 $149,000
Q1 2020 May 15, 2020	SELL	$4.24 - $9.89 $94,780 - $221,081	-22,354 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.56 - $8.78 $101,934 - $196,268	22,354 New	22,354 $190,000

27.9M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $226M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.